Transient deSUMOylation of IRF2BP proteins controls early transcription in EGFR signaling.
Sina V BaryschNicolas Stankovic-ValentinTim MiedemaSamir KaracaJudith DoppelThiziri Nait AchourAarushi VasudevaLucie WolfCarsten StichtHenning UrlaubFrauke MelchiorPublished in: EMBO reports (2021)
Molecular switches are essential modules in signaling networks and transcriptional reprogramming. Here, we describe a role for small ubiquitin-related modifier SUMO as a molecular switch in epidermal growth factor receptor (EGFR) signaling. Using quantitative mass spectrometry, we compare the endogenous SUMO proteomes of HeLa cells before and after EGF stimulation. Thereby, we identify a small group of transcriptional coregulators including IRF2BP1, IRF2BP2, and IRF2BPL as novel players in EGFR signaling. Comparison of cells expressing wild type or SUMOylation-deficient IRF2BP1 indicates that transient deSUMOylation of IRF2BP proteins is important for appropriate expression of immediate early genes including dual specificity phosphatase 1 (DUSP1, MKP-1) and the transcription factor ATF3. We find that IRF2BP1 is a repressor, whose transient deSUMOylation on the DUSP1 promoter allows-and whose timely reSUMOylation restricts-DUSP1 transcription. Our work thus provides a paradigm how comparative SUMO proteome analyses serve to reveal novel regulators in signal transduction and transcription.
Keyphrases
- transcription factor
- epidermal growth factor receptor
- dendritic cells
- tyrosine kinase
- small cell lung cancer
- cell cycle arrest
- induced apoptosis
- advanced non small cell lung cancer
- wild type
- mass spectrometry
- genome wide identification
- dna binding
- gene expression
- poor prognosis
- immune response
- cell death
- endoplasmic reticulum stress
- small molecule
- cerebral ischemia
- genome wide
- high resolution
- single cell
- dna methylation
- pi k akt
- long non coding rna
- oxidative stress
- simultaneous determination
- gas chromatography
- binding protein